Search research articles
Contact Us
Filters
Showing results (311-320 of 331) with videos related to
Page
of 34
Sort By:
Journal of Medicinal Chemistry
|
April 23, 2015
Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the δ-opioid receptor
Neil T Burford, Kathryn E Livingston, Meritxell Canals, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2018
Structure-based discovery of selective positive allosteric modulators of antagonists for the M<sub>2</sub> muscarinic acetylcholine receptor
Magdalena Korczynska, Mary J Clark, Celine Valant, et al.
Acta Pharmaceutica Sinica. B
|
February 23, 2023
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives and identification of a radiofluorinated probe for imaging the muscarinic acetylcholine receptor M<sub>4</sub>
Ahmed Haider, Xiaoyun Deng, Olivia Mastromihalis, et al.
British Journal of Pharmacology
|
November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P H Alexander, Eamonn Kelly, Alistair Mathie, et al.
ACS Pharmacology & Translational Science
|
March 29, 2020
The Molecular Control of Calcitonin Receptor Signaling
Emma Dal Maso, Alisa Glukhova, Yue Zhu, et al.
Elife
|
April 27, 2021
A robust method for particulate detection of a genetic tag for 3D electron microscopy
James Rae, Charles Ferguson, Nicholas Ariotti, et al.
Nature
|
January 10, 2020
Activation of the GLP-1 receptor by a non-peptidic agonist
Peishen Zhao, Yi-Lynn Liang, Matthew J Belousoff, et al.
BMJ Open Diabetes Research & Care
|
November 16, 2021
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
Darren M Riddy, Helene L Kammoun, Andrew J Murphy, et al.
ACS Pharmacology & Translational Science
|
March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>
Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
ACS Chemical Neuroscience
|
April 22, 2018
Discovery and Optimization of Potent and CNS Penetrant M<sub>5</sub>-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold
Aaron M Bender, Hyekyung P Cho, Kellie D Nance, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 331) with videos related to
Sort By:
Page
of 34
Journal of Medicinal Chemistry
|
April 23, 2015
Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the δ-opioid receptor
Neil T Burford, Kathryn E Livingston, Meritxell Canals, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2018
Structure-based discovery of selective positive allosteric modulators of antagonists for the M<sub>2</sub> muscarinic acetylcholine receptor
Magdalena Korczynska, Mary J Clark, Celine Valant, et al.
Acta Pharmaceutica Sinica. B
|
February 23, 2023
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives and identification of a radiofluorinated probe for imaging the muscarinic acetylcholine receptor M<sub>4</sub>
Ahmed Haider, Xiaoyun Deng, Olivia Mastromihalis, et al.
British Journal of Pharmacology
|
November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P H Alexander, Eamonn Kelly, Alistair Mathie, et al.
ACS Pharmacology & Translational Science
|
March 29, 2020
The Molecular Control of Calcitonin Receptor Signaling
Emma Dal Maso, Alisa Glukhova, Yue Zhu, et al.
Elife
|
April 27, 2021
A robust method for particulate detection of a genetic tag for 3D electron microscopy
James Rae, Charles Ferguson, Nicholas Ariotti, et al.
Nature
|
January 10, 2020
Activation of the GLP-1 receptor by a non-peptidic agonist
Peishen Zhao, Yi-Lynn Liang, Matthew J Belousoff, et al.
BMJ Open Diabetes Research & Care
|
November 16, 2021
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
Darren M Riddy, Helene L Kammoun, Andrew J Murphy, et al.
ACS Pharmacology & Translational Science
|
March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>
Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
ACS Chemical Neuroscience
|
April 22, 2018
Discovery and Optimization of Potent and CNS Penetrant M<sub>5</sub>-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold
Aaron M Bender, Hyekyung P Cho, Kellie D Nance, et al.
Page
of 34